We report an unusual combination of features comprising delayed tooth eruption and closure of the anterior fontanel as the sole presenting features in a child with cleidocranial dysplasia (CCD). Radiological survey revealed the presence of wormian bones in the skull, pseudoepiphysis at the base of the bilateral second metacarpal, and midline ossification defects at pubic symphysis in the presence of essentially normal clavicles. DNA sequencing of the RUNX2 gene detected a novel nonsense mutation in exon1 (c.166C>T; p.Q56X) in its glutamine-alanine (Q/A) repeat domain. The genotypes of all published cases of CCD with normal clavicles were reviewed. Additional dental and otolaryngological features were enlisted. Three cases with a milder dental phenotype and normal clavicles were associated with a mutation in the Q/A domain. Collectively, we found a novel CCD-causing nonsense mutation p.Q56X in the Q/A domain of the RUNX2 gene.

1.
Baumert U, Golan I, Redlich M, Aknin JJ, Muessig D: Cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group. Am J Med Genet A 139A:78-85 (2005).
2.
Cole WR, Levine S: Cleidocranial dysostosis. Br J Radiol 24:549-555 (1951).
3.
Heyworth BE, Osei DA, Fabricant PD, Schneider R, Doyle SM, et al: The shorthand bone age assessment: a simpler alternative to current methods. J Pediatr Orthop 33:569-574 (2013).
4.
Jain S, Chowdhury V, Juneja M, Kabra M, Pandey S, et al: Intellectual disability in Indian children: experience with a stratified approach for etiological diagnosis. Indian Pediatr 50:1125-1130 (2013).
5.
Jensen BL: Somatic development in cleidocranial dysplasia. Am J Med Genet 35:69-74 (1990).
6.
Kim HJ, Nam SH, Kim HJ, Park HS, Ryoo HM, et al: Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J Cell Physiol 207:114-122 (2006).
7.
Lin WD, Lin SP, Wang CH, Tsai Y, Chen CP, et al: RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia. Genet Mol Biol 34:201-204 (2011).
8.
Marie P, Sainton P: On hereditary cleido-cranial dysostosis. Rev Neurol 6:835 (1898).
9.
Mundlos S: Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 36:177-182 (1999).
10.
Rimoin DL: International nomenclature of constitutional diseases of bone. J Pediatr 93:614-618 (1978).
11.
Stocks P, Barrington A: Treasury of Human Inheritance. (Cambridge University Press, London 1925).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.